Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus

Journal of Clinical Immunology

Volumn 28, Issue 2, 2008, Pages 131-133

  Marasini, Bianca ^a   Massarotti, Marco ^a   De Monti, Marco ^b   Erario, Maddalena ^b   Ghilardi, Giorgio ^b   Biondi, Maria Luisa ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

Atherosclerosis; Carotid intimal medial thickness; Stromelysin polymorphism; Systemic lupus erythematosus

Indexed keywords

STROMELYSIN;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; B SCAN; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; CAROTID ARTERY DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUNICA INTIMA;

EID: 40149084552     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-007-9146-3     Document Type: Article

References (17)

1. Björnadål L, Yin L, Granath F, Klareskog L, Ekbom A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol. 2004;31:713-9.
2. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2003;62:1071-7.
3. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, et al. Camparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum. 2004;50:151-9.
4. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44:2331-7.
5. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad and the ugly. Circ Res. 2002;90:251-62.
6. Uzui H, Harpf A, Liu M, Doherty TM, Shukla A, Chai NN, et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation. 2002;106:3024-30.
7. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 1995;73:209-15.
8. Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke. 2002;33:2408-12.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7.
10. Stein JH, Korcarz CE, Mays ME, Douglas PS, Zhang H, Lacaire T, et al. A semiautomated ultrasound border detection program that facilitates clinical measurement of ultrasound carotid intima-media thickness. J Am Soc Echocardiogr. 2005;18:244-51.
11. Mukherjee D, Yadav JS. Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J. 2002;144:753-9.
12. Sposito AC, Gonbert S, Turpin G, Chapman MJ, Thillet J. Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol. Arterioscler Thromb Vasc Biol. 2004;24:2192-5.
13. Wang D, Yang H, Quinones MJ, Bulnes-Enriquez I, Jimenez X, De La Rosa R, et al. A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease Family Study. Stroke. 2005;36:540-5.
14. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov RCrow MK, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399-40.
15. Gnasso A, Motti C, Irace C, Carallo C, Liberatoscioli L, Bernardini S, et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol. 2000;20:1600-5.
16. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke. 2002;33:1420-3.
17. Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol. 2003;41:2130-7.